Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lerín, C.
Right arrow Articles by Gómez-Foix, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lerín, C.
Right arrow Articles by Gómez-Foix, A. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:2221-2226, 2003
© 2003 by the American Diabetes Association, Inc.

Regulation and Function of the Muscle Glycogen-Targeting Subunit of Protein Phosphatase 1 (GM) in Human Muscle Cells Depends on the COOH-Terminal Region and Glycogen Content

Carlos Lerín1, Eulàlia Montell1, Teresa Nolasco1, Cathy Clark2, Matthew J. Brady3, Christopher B. Newgard2, and Anna M. Gómez-Foix1

1 Department de Bioquímica i Biologia Molecular, Universitat de Barcelona, Barcelona, Spain
2 Sarah Stedman Center for Nutritional Studies, and Departments of Pharmacology and Cancer Biology, Biochemistry, and Medicine, Duke University Medical Center, Durham, North Carolina
3 Department of Medicine, Section on Endocrinology, University of Chicago, Chicago, Illinois

GM, the muscle-specific glycogen-targeting subunit of protein phosphatase 1 (PP1) targeted to the sarcoplasmic reticulum, was proposed to regulate recovery of glycogen in exercised muscle, whereas mutation truncation of its COOH-terminal domain is known to be associated with type 2 diabetes. Here, we demonstrate differential effects of GM overexpression in human muscle cells according to glycogen concentration. Adenovirus-mediated delivery of GM slightly activated glycogen synthase (GS) and inactivated glycogen phosphorylase (GP) in glycogen-replete cells, causing an overaccumulation of glycogen and impairment of glycogenolysis after glucose deprivation. Differently, in glycogen-depleted cells, GM strongly increased GS activation with no further enhancement of early glycogen resynthesis and without affecting GP. Effects of GM on GS and GP were abrogated by treatment with dibutyryl cyclic AMP. Expression of a COOH-terminal deleted-mutant (GM{Delta}C), lacking the membrane binding sequence to sarcoplasmic reticulum, failed to activate GS in glycogen-depleted cells, while behaving similar to native GM in glycogen-replete cells. This is explained by loss of stability of the GM{Delta}C protein following glycogen-depletion. In summary, GM promotes glycogen storage and inversely regulates GS and GP activities, while, specifically, synthase phosphatase activity of GM-PP1 is inhibited by glycogen. The conditional loss of function of the COOH-terminal deleted GM construct may help to explain the reported association of truncation mutation of GM with insulin resistance in human subjects.


Address correspondence and reprint requests to Anna M. Gómez-Foix, Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, E-08028, Barcelona, Spain. E-mail: agomez{at}bq.ub.es


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Xiong, Q. F. Collins, J. An, E. Lupo Jr., H.-Y. Liu, D. Liu, J. Robidoux, Z. Liu, and W. Cao
p38 Mitogen-activated Protein Kinase Plays an Inhibitory Role in Hepatic Lipogenesis
J. Biol. Chem., February 16, 2007; 282(7): 4975 - 4982.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Cao, Q. F. Collins, T. C. Becker, J. Robidoux, E. G. Lupo Jr., Y. Xiong, K. W. Daniel, L. Floering, and S. Collins
p38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis
J. Biol. Chem., December 30, 2005; 280(52): 42731 - 42737.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. B. Jorgensen, J. N. Nielsen, J. B. Birk, G. S. Olsen, B. Viollet, F. Andreelli, P. Schjerling, S. Vaulont, D. G. Hardie, B. F. Hansen, et al.
The {alpha}2-5'AMP-Activated Protein Kinase Is a Site 2 Glycogen Synthase Kinase in Skeletal Muscle and Is Responsive to Glucose Loading
Diabetes, December 1, 2004; 53(12): 3074 - 3081.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.